Tolerance and clinical response to SGL2 inhibitors in Fabry disease

被引：0
|
作者：
Mattig, I. [1 ]
Bonnekoh, C. [2 ]
Zirkelbach, B. [1 ]
Stangl, K. [1 ]
Hindricks, G. [1 ]
Knebel, F. [3 ]
Canaan-Kuehl, S. [2 ]
Spethmann, S. [1 ]
机构：
[1] Charite, Deutsch Herzzentrum Charite, Berlin, Germany
[2] Charite, Berlin, Germany
[3] Sana Klinikum Berlin Lichtenberg, Cardiol, Berlin, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [31] Fabry disease with few clinical signs and symptoms
    Asahi, K
    Katoh, T
    Watanabe, K
    Watanabe, T
    INTERNAL MEDICINE, 2002, 41 (11) : 983 - 985
  • [32] Clinical characteristics of cerebral microbleeds in Fabry Disease
    Kono, Y.
    Komatsu, T.
    Miyagawa, S.
    Sakamoto, Y.
    Hirai, T.
    Mitsumura, H.
    Kamiyama, T.
    Wakabayashi, T.
    Kobayashi, M.
    Ohashi, T.
    Eto, Y.
    Ida, H.
    Iguchi, Y. Yasuyuki
    CEREBROVASCULAR DISEASES, 2014, 37 : 578 - 578
  • [33] Clinical manifestations of Japanese heterozygotes with Fabry disease
    Kobayashi, M.
    Ohashi, T.
    Ida, H.
    Eto, Y.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 137 - 137
  • [34] The clinical role of the pulvinar sign in Fabry disease
    Burlina, A. P.
    Manara, R.
    Caillaud, C.
    Laissy, J. P.
    Klein, I
    Severino, M.
    Burlina, A. B.
    Lidove, O.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 104 - 104
  • [35] Clinical utility gene card for: Fabry disease
    Gal, Andreas
    Beck, Michael
    Winchester, Bryan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2012, 20 (02) : 3 - 3
  • [36] Clinical utility gene card for: Fabry disease
    Andreas Gal
    Michael Beck
    Bryan Winchester
    European Journal of Human Genetics, 2012, 20 : 3 - 3
  • [37] Diagnosis of Fabry disease: usefulness of the clinical investigation
    Demontis, R.
    REVUE DE MEDECINE INTERNE, 2010, 31 : S229 - S232
  • [38] Clinical characteristics of Hungarian patients with Fabry disease
    Rakoczi, E.
    Gorogh, S.
    Grubits, J.
    Erdos, M.
    Garzuly, F.
    Hahn, K.
    Bencsik, K.
    Trinn, C.
    Steiber, Z.
    Kristof, L.
    Kovacs, G.
    Toth, B.
    Mogyorosi, G.
    Marodi, L.
    CLINICAL THERAPEUTICS, 2007, 29 : S19 - S19
  • [39] FAbry STabilization indEX (FASTEX): Clinical evaluation of disease progression in Fabry patients
    Lenders, Malte
    Brand, Eva
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : 142 - 149
  • [40] Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey
    Ramaswami, U
    Whybra, C
    Parini, R
    Pintos-Morell, G
    Mehta, A
    Sunder-Plassmann, G
    Widmer, U
    Beck, M
    ACTA PAEDIATRICA, 2006, 95 (01) : 86 - 92
12345